A paradigm shift in cardiac pacing therapy?
نویسندگان
چکیده
Artificial pacemakers have been continuously improved since 1949, when Jack Hopps, from the National Research Council of Canada in Ottawa, first assembled an external generator for Wilfred Bigelow and John Callaghan in the basement of the Banting Institute at the University of Toronto.1 Although Hopps’ device was not the first artificial pacemaker,2–4 the presentation by Callaghan at the 1950 American College of Surgeons meeting in Boston, Mass, stimulated a surge of experimentation that quickly led to demonstration of the utility of cardiac pacing in humans and subsequent manufacture of implantable devices.3 Since that time, remarkable advances in lead design, battery duration, programming capability, and electronic circuitry have given rise to one of the most successful and accepted life-saving, palliative therapies in modern medicine.3,5 Furthermore, medical indications for pacing therapy have expanded beyond the management of symptomatic bradycardia to include treatments for hypertrophic cardiomyopathy, neurocardiogenic syncope, ventricular tachyarrhythmia, congestive heart failure, and atrial fibrillation.6,7 Nevertheless, in spite of the fact that pacemakers represent a state-of-the-art technology, there are significant problems associated with long-term cardiac pacing.
منابع مشابه
Challenges in cardiac resynchronization therapy-defibrillator upgrade in a patient with right pneumonectomy.
متن کامل
A new paradigm for physiologic ventricular pacing.
Clinical trials in patients with pacemakers for sinus node dysfunction or atrioventricular block (AVB) and implantable cardioverter-defibrillators provide increasing evidence showing that desynchronization of ventricular electrical activation and contraction, induced by conventional right ventricular apex (RVA) pacing, is a serious threat for long-term cardiac morbidity and mortality. The risk ...
متن کامل[Antitachycardia pacing efficacy significantly improves with cardiac resynchronization therapy].
INTRODUCTION AND OBJECTIVES The effect of cardiac resynchronization therapy on antitachycardia pacing still has to be determined. PATIENTS AND METHOD A total of 490 heart failure patients with an indication for an implantable cardioverter-defibrillator participated in the VENTAK CHF/CONTAK CD study, a single-blind, randomized, placebo-controlled study. We compared antitachycardia pacing effic...
متن کاملHigh impedance leads and safety margin. Electrical considerations based on a simplified expression of the 'paradigm'.
For physicians who are not familiar with the electrical basis of cardiac stimulation, high impedance leads previously (10 years ago) considered as bad electrodes (high voltage) are now considered as the 'epitome' of lead technology (low energy drain): clearly impedance is not a good parameter for characterizing the qualities of a pacing lead. Using a simplified approach to the electrostimulatio...
متن کاملThe effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy.
Cardiac pacing is the only effective treatment for patients with sick sinus syndrome and atrioventricular conduction disorders. In cardiac pacing, the endocardial pacing lead is typically positioned at the right ventricular (RV) apex. At the same time, there is increasing indirect evidence, derived from large pacing mode selection trials and observational studies, that conventional RV apical pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation
دوره 114 10 شماره
صفحات -
تاریخ انتشار 2006